Recombinant human BUD13 protein; Source: E. coli derived, PET28a; Tag: 6*His; Domain: 260-619 aa of BC006350
Conjugate
Unconjugated
Applications
Application Notes
IHC: 1:200-1:800 IF/ICC: 1:50-1:500
General Notes
This product (Catalog No. CABT-BL478) is a rabbit-derived polyclonal antibody raised against human BUD13, targeting the amino acid region 260–619 of the protein. This antibody exhibits cross-reactivity with Human BUD13 from mouse. It has been affinity purified by Protein A. BUD13 homolog (BUD13) is a component of the retention and splicing (RES) complex, previously identified in yeast as a splicing factor affecting nuclear pre-mRNA retention. As an RNA binding protein (RBP), BUD13 expression is associated with poor prognosis and may be involved in the development and progression of hepatocellular carcinoma (PMID: 37605593). CABT-BL478 is suitable for use in IHC (1:200–1:800), IF/ICC (1:50–1:500) applications. CABT-BL478 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human BUD13 (a.a. 260-619) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.